AstraZeneca is seeking FDA approval to market Seroquel XR for treating depression and anxiety.

阿斯利康正在征求FDA批准奎硫平缓释片用于治疗抑郁症和焦虑症。

Seroquel XR is an extended release version of the medicine with a longer patent life than the original formulation.

奎硫平缓释片是该药的一个延长释放的版本。 它比奎硫平有更长的专利寿命。